LYEL · Company research
Lyell Immunopharma, Inc. Common Stock (LYEL): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 8.56 | $227,565,360 | 154580360.00 | — | — | — | 56891.340000000000 | 0.97327100485426512414 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.